DeepDOF Imaging for Cervical Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new imaging method, DeepDOF, to improve cervical cancer diagnosis. It focuses on women undergoing cervical biopsies or LEEP procedures, standard tests for cervical cancer. The aim is to determine how well DeepDOF images enhance the accuracy of these tests. Women aged 25-49 undergoing a cervical biopsy or LEEP may be suitable candidates. As an unphased trial, this study allows participants to contribute to innovative research that could enhance diagnostic accuracy for future patients.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that DeepDOF Imaging is safe for cervical cancer diagnosis?
Research shows that the DeepDOF imaging technique uses advanced computer methods to enhance the quality of cervical cancer images. These methods achieve a success rate of about 99.26% in producing clear images, aiding doctors in detecting early signs of cervical cancer more reliably.
Studies have developed computer programs that automatically identify early and advanced stages of cervical cancer from these images. This automation aims to make cervical cancer screening faster and more accurate.
No reports of side effects or safety concerns related to the DeepDOF imaging process have emerged in the studies reviewed. Since this trial tests an imaging technique rather than a new drug or invasive procedure, it is generally expected to be safe. Imaging methods like this are usually considered safe because they do not involve surgery or medication.12345Why are researchers excited about this trial?
Researchers are excited about DeepDOF Imaging for cervical cancer because it offers a new way to visualize cervical tissue in real-time. Unlike standard care, such as VIA (visual inspection with acetic acid) or colposcopy, which can be subjective, DeepDOF provides immediate, high-resolution images at the point of care. This technique could lead to faster and potentially more accurate identification of abnormal cells, enabling quicker decision-making for further treatment. By providing clear images right away, DeepDOF could revolutionize how cervical cancer screenings are conducted, making them more efficient and potentially more effective.
What evidence suggests that DeepDOF Imaging is effective for cervical cancer?
Research has shown that DeepDOF Imaging, which employs advanced computer techniques, can detect cervical cancer more effectively. Studies have found these methods to be highly accurate, with some tests achieving 96.84% and 94.50% accuracy in identifying types of cervical cancer. In this trial, participants will undergo imaging with DeepDOF, which helps locate and outline tumors in images, potentially leading to better treatment options. By improving early detection, DeepDOF Imaging could significantly enhance care and outcomes for people with cervical cancer.12678
Who Is on the Research Team?
Kathleen M Schmeler, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for women aged 25-49 in Mozambique and Brazil who are undergoing cervical biopsy or LEEP, not pregnant, and able to give informed consent. Pregnant women, those outside the age range, or not having the procedures cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cervical biopsy and/or LEEP procedures, and specimens are imaged using DeepDOF at the point of care
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- DeepDOF Images
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor